Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Listen to this Section


$13.43
-0.5300 ( -3.80% ) 746.8K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 104 Feb 05, 2024
3 Insider transactions 1 Feb 01, 2024
4 Insider transactions 1 Feb 01, 2024
4 Insider transactions 1 Jan 30, 2024
4 Insider transactions 1 Jan 26, 2024
4 Insider transactions 1 Jan 26, 2024
8-k 8K-related 21 Jan 22, 2024
8-k 8K-related 15 Jan 17, 2024
8-k 8K-related 13 Jan 17, 2024
8-k/a 8K-related 16 Jan 17, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.